Automatic identification of clinically important Aspergillus species by artificial intelligence-based image recognition: proof-of-concept study
- PMID: 39585232
- PMCID: PMC11632928
- DOI: 10.1080/22221751.2024.2434573
Automatic identification of clinically important Aspergillus species by artificial intelligence-based image recognition: proof-of-concept study
Abstract
While morphological examination is the most widely used for Aspergillus identification in clinical laboratories, PCR-sequencing and MALDI-TOF MS are emerging technologies in more financially-competent laboratories. However, mycological expertise, molecular biologists and/or expensive equipment are needed for these. Recently, artificial intelligence (AI), especially image recognition, is being increasingly employed in medicine for fast and automated disease diagnosis. We explored the potential utility of AI in identifying Aspergillus species. In this proof-of-concept study, using 2813, 2814 and 1240 images from four clinically important Aspergillus species for training, validation and testing, respectively; the performances and accuracies of automatic Aspergillus identification using colonial images by three different convolutional neural networks were evaluated. Results demonstrated that ResNet-18 outperformed Inception-v3 and DenseNet-121 and is the best algorithm of choice because it made the fewest misidentifications (n = 8) and possessed the highest testing accuracy (99.35%). Images showing more unique morphological features were more accurately identified. AI-based image recognition using colonial images is a promising technology for Aspergillus identification. Given its short turn-around-time, minimal demand of expertise, low reagent/equipment costs and user-friendliness, it has the potential to serve as a routine laboratory diagnostic tool after the database is further expanded.
Keywords: Aspergillus; artificial intelligence; automation; identification; image recognition; machine learning.
Conflict of interest statement
Patrick C. Y. Woo has provided scientific advisory/laboratory services for Gilead Sciences, Incorporated; International Health Management Associates, Incorporated; Merck & Corporation, Incorporated; Micología Molecular S.L. and Pfizer, Incorporated. The other authors report no conflict of interest.
Figures
References
-
- Tarka P, Nitsch-Osuch A, Gorynski P, et al. . Epidemiology of pulmonary aspergillosis in hospitalized patients in Poland during 2009–2016. In: Pokorski M, editor. Advances in pulmonary medicine: research and innovations. Cham: Springer; 2019. p. 73–80. - PubMed
-
- Koehler P, Bassetti M, Kochanek M, et al. . Intensive care management of influenza-associated pulmonary aspergillosis. Clin Microbiol Infect. 2019;25:1501–1509. - PubMed
-
- Holding KJ, Dworkin MS, Wan P-CT, et al. . Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Clin Infect Dis. 2000;31:1253–1257. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical